Biorem Inc. (BRM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 140 | 185 | 75 | 74 | 197 |
| Income taxes - deferred | -652 | 792 | 123 | 121 | 512 |
| Accounts receivable | -4,905 | 2,138 | -3,346 | 6,352 | -6,462 |
| Accounts payable and accrued liabilities | -934 | 269 | 495 | -2,346 | 2,675 |
| Other Working Capital | -1,413 | -125 | -2,489 | 3,586 | -3,094 |
| Other Operating Activity | 6,074 | -165 | 3,245 | -3,608 | 6,210 |
| Operating Cash Flow | $-1,690 | $3,095 | $-1,898 | $4,178 | $38 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | 0 | -4 | -363 | 121 |
| Investing Cash Flow | $-5 | $0 | $-4 | $-363 | $121 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -130 | -202 | -170 | -228 | 677 |
| Other Financing Activity | 157 | 0 | 0 | 0 | -775 |
| Financing Cash Flow | $27 | $-202 | $-170 | $-228 | $-98 |
| Exchange Rate Effect | -394 | 478 | 73 | 23 | -153 |
| Beginning Cash Position | 7,275 | 3,904 | 5,902 | 2,292 | 2,383 |
| End Cash Position | 5,213 | 7,275 | 3,904 | 5,902 | 2,292 |
| Net Cash Flow | $-1,668 | $2,893 | $-2,071 | $3,587 | $62 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,690 | 3,095 | -1,898 | 4,178 | 38 |
| Capital Expenditure | -5 | N/A | -4 | -363 | N/A |
| Free Cash Flow | -1,695 | 3,095 | -1,901 | 3,815 | 38 |